Balchem Management
Management criteria checks 4/4
Balchem's CEO is Ted Harris, appointed in Apr 2015, has a tenure of 9.25 years. total yearly compensation is $5.89M, comprised of 19.6% salary and 80.4% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth $7.34M. The average tenure of the management team and the board of directors is 2.2 years and 5.6 years respectively.
Key information
Ted Harris
Chief executive officer
US$5.9m
Total compensation
| CEO salary percentage | 19.6% |
| CEO tenure | 9.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.2yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29
Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?
Aug 22Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?
Aug 08Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement
May 30Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
May 18Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
May 02Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Mar 28Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Feb 26Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Dec 23Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Nov 18We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Sep 22Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Aug 16Balchem: Good Quarterly Performance Priced In
Aug 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$115m |
| Dec 31 2023 | US$6m | US$1m | US$109m |
| Sep 30 2023 | n/a | n/a | US$103m |
| Jun 30 2023 | n/a | n/a | US$99m |
| Mar 31 2023 | n/a | n/a | US$99m |
| Dec 31 2022 | US$12m | US$1m | US$105m |
| Sep 30 2022 | n/a | n/a | US$109m |
| Jun 30 2022 | n/a | n/a | US$109m |
| Mar 31 2022 | n/a | n/a | US$102m |
| Dec 31 2021 | US$6m | US$1m | US$96m |
| Sep 30 2021 | n/a | n/a | US$93m |
| Jun 30 2021 | n/a | n/a | US$90m |
| Mar 31 2021 | n/a | n/a | US$88m |
| Dec 31 2020 | US$5m | US$1m | US$85m |
| Sep 30 2020 | n/a | n/a | US$83m |
| Jun 30 2020 | n/a | n/a | US$82m |
| Mar 31 2020 | n/a | n/a | US$81m |
| Dec 31 2019 | US$4m | US$915k | US$80m |
| Sep 30 2019 | n/a | n/a | US$80m |
| Jun 30 2019 | n/a | n/a | US$78m |
| Mar 31 2019 | n/a | n/a | US$78m |
| Dec 31 2018 | US$3m | US$800k | US$79m |
| Sep 30 2018 | n/a | n/a | US$100m |
| Jun 30 2018 | n/a | n/a | US$97m |
| Mar 31 2018 | n/a | n/a | US$94m |
| Dec 31 2017 | US$2m | US$700k | US$90m |
Compensation vs Market: Ted's total compensation ($USD5.89M) is below average for companies of similar size in the US market ($USD8.45M).
Compensation vs Earnings: Ted's compensation has been consistent with company performance over the past year.
CEO
Ted Harris (59 yo)
9.3yrs
Tenure
US$5,889,707
Compensation
Mr. Theodore L. Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 30...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 9.3yrs | US$5.89m | 0.15% $ 7.3m | |
| Executive VP | 5.4yrs | US$1.78m | 0.045% $ 2.3m | |
| Executive VP | 2yrs | US$1.12m | 0.00091% $ 45.5k | |
| Senior VP & Chief Supply Chain Officer | 3.5yrs | US$1.15m | 0.012% $ 613.6k | |
| Senior VP and GM of Human Nutrition & Health | 1.7yrs | US$1.14m | 0.0025% $ 124.4k | |
| VP & Chief Accounting Officer | 13.1yrs | US$960.42k | 0.018% $ 911.4k | |
| Senior VP & CTO | 1.8yrs | no data | 0.015% $ 751.5k | |
| Senior Vice President of Corporate Development | less than a year | US$1.01m | 0.039% $ 2.0m | |
| Senior VP & Chief Human Resources Officer | 2.4yrs | no data | 0.026% $ 1.3m | |
| Senior VP & GM of Specialty Products | 1.8yrs | no data | no data |
2.2yrs
Average Tenure
48yo
Average Age
Experienced Management: BCPC's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 9.3yrs | US$5.89m | 0.15% $ 7.3m | |
| Independent Director | 6.4yrs | US$226.26k | 0.011% $ 534.6k | |
| Independent Director | 13.8yrs | US$211.26k | 0.028% $ 1.4m | |
| Lead Independent Director | 8.8yrs | US$231.26k | 0.014% $ 706.0k | |
| Independent Director | less than a year | US$21.67k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$211.26k | 0.022% $ 1.1m | |
| Independent Director | 3.1yrs | US$218.76k | 0.0027% $ 136.4k | |
| Independent Director | less than a year | US$21.67k | 0% $ 0 |
5.6yrs
Average Tenure
59.5yo
Average Age
Experienced Board: BCPC's board of directors are considered experienced (5.6 years average tenure).